The Role of Tumor-Free Status in Repeat Resection Before Intravesical Bacillus Calmette-Guerin for High Grade Ta, T1 and CIS Bladder Cancer
Author:
Affiliation:
1. Institut National en Santé et Recherche Médicale U955 EQ7, Departments of Urology and Pathology Assistance Publique-Hôpitaux de Paris, Centre Hospitalier Universitaire Henri Mondor, Créteil, France
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference18 articles.
1. Guidelines for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update;Hall;J Urol,2007
2. European Association of Urology Guidelines on Ta, T1 (Non-Muscle Invasive) Bladder Cancer;Babjuk,2008
3. Current approaches to the management of non-muscle invasive bladder cancer: comparison of current guidelines and recommendations;Persad;Eur Urol,2008
4. Management of stage T1 tumors of the bladder: international consensus panel;Nieder;Urology,2005
5. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?;Brauers;J Urol,2001
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of staging MRI to re‐resection for localised bladder cancer: Narrative review;BJUI Compass;2024-04-24
2. Prediction of Non-Muscle Invasive Papillary Urothelial Carcinoma Relapse from Hematoxylin–Eosin Images Using Deep Multiple Instance Learning in Patients Treated with Bacille Calmette–Guérin Immunotherapy;Biomedicines;2024-02-03
3. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy;Japanese Journal of Clinical Oncology;2023-11-16
4. Does repeat transurethral resection of bladder tumor influence the diagnosis and prognosis of T1 bladder cancer? A systematic review and meta-analysis;European Journal of Surgical Oncology;2023-01
5. Kommentar zu Transurethrale Blasentumorresektion: Werden die Qualitätsanforderungen erfüllt?;Aktuelle Urologie;2022-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3